We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Bioabsorbable Stent/Bioresorbable Scaffold Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The Global Bioabsorbable Stent/Bioresorbable Scaffold Market was valued at USD 222.84 million in 2016 and is projected to reach USD 586.41 million by 2025, growing at a CAGR of 11.1% from 2017 to 2025.

A stent is any device which is inserted into a blood vessel or other internal duct in order to expand the vessel to prevent or alleviate a blockage.A bioresorbable stent, (also called biodegradable or naturally-dissolving) serves the same purpose, but is manufactured from a material that may dissolve or be absorbed in the body. The demand in market has increased because of the long term benefits which are not provided by traditional stents.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Non fluctuating Demands in Market
1.2 Growing demand for in older age group due to risk of CAD and PAD

2. Market Restraints
2.1 Competition provided by substitutes

Market Segmentation:
1. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Absorption Rate:
1.1 Slow Absorption rate
1.2 Fast absorption rate

2. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Material:
2.1 Bioresorbable Polymer-Based Stents
2.2 Bioresorbable Metallic Stents

3. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by End User:
3.1 Hospitals
3.2 Cardiac Centers

4. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Application:
4.1 Coronary Artery Disease
4.2 Peripheral Artery Disease

5. Global Bioabsorbable Stent/Bioresorbable Scaffold Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Abbott
2. REVA Medical, Inc.
3. Elixir Medical Corporation
4. KYOTO MEDICAL PLANNING Co., Ltd.
5. BIOTRONIK
6. Amaranth Medical, Inc.
7. Arterial Remodeling Technologies
8. Meril Life Sciences Pvt. Ltd.
9. Arterius Limited
10. LEPU MEDICAL TECHNOLOGY CO., LTD.
11. Boston Scientific Corporation
12. 480 Biomedical
13. S3V Vascular Technologies Private Limited
14. Qualimed (Part of Q3 Medical Group)
15. ORBUSNEICH

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Bioabsorbable Stent/Bioresorbable Scaffold Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY ABSORPTION RATE
5.1 Slow Absorption rate
5.2 Fast absorption rate

6 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY MATERIAL
6.1 Bioresorbable Polymer-Based Stents
6.2 Bioresorbable Metallic Stents

7 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY END USER
7.1 Hospitals
7.2 Cardiac Centers

8 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY APPLICATION
8.1 Coronary Artery Disease
8.2 Peripheral Artery Disease

9 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Abbott
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 REVA Medical, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Elixir Medical Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Kyoto Medical Planning Co., Ltd.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 BIOTRONIK
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Amaranth Medical, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Arterial Remodeling Technologies
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Meril Life Sciences Pvt. Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Arterius Limited
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Boston Scientific Corporation
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 480 Biomedical
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 S3V Vascular Technologies Private Limited
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

11.14 Qualimed
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments

11.15 ORBUSNEICH
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments

12 Appendix
12.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved